0X4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AgeX Therapeutics Inc

Watchlist Manager

Watchlist

Price: 17.4443 EUR Market Closed

Market Cap: €1.5B

	AgeX Therapeutics Inc F:0X4	US
I	IVisionWorks Co Ltd KOSDAQ:469750	KR
	PCC Exol SA F:9B2	PL
	CLS Holdings USA Inc OTC:CLSH	US
S	Suzhou Iron Technology Co Ltd SSE:688329	CN
K	Kanco Tea & Industries Ltd BSE:541005	IN
	Soon Hock Enterprise Holding Ltd SGX:SHE	SG
	China Natural Resources Inc NASDAQ:CHNR	HK
R	Rostelekom PAO MOEX:RTKM	RU
A	AFB Ltd OTC:AFBL	HK

Profitability Summary

AgeX Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

14%

Negative Operating Margin

-18 478%

Negative 3Y Average Operating Margin

-11 975%

Declining Operating Margin

-18 450% > -18 478%

Negative Net Margin

-14 755%

Negative 3Y Average Net Margin

-10 442%

Net Margin is Increasing

-27 725% > -14 755%

Negative Free Cash Flow Margin

-13 857%

Negative 3Y Average Free Cash Flow Margin

-11 669%

Free Cash Flow Margin is Increasing

-16 100% > -13 857%

Negative ROE

-6 352%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-819%

Declining ROIC

-112% > -1 126%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.